Explore the latest in chronic kidney disease from The JAMA Network, including recent guidelines and advances in staging and management of the disorder.
This systematic review and meta-analysis of randomized clinical trials investigates if more intensive compared with less intensive blood pressure control is associated with reduced mortality risk in persons with chronic kidney disease stages 3 to 5.
This meta-analysis compares intensive blood pressure control (<130/80 mm Hg) with standard blood pressure control (<140/90 mm Hg) on major renal outcomes in patients with chronic kidney disease without diabetes.
This cohort study assesses the prospective association of coronary artery calcification with risk of cardiovascular disease and all-cause mortality among dialysis-naive adult patients with chronic kidney disease from 7 US clinical centers.
This study surveyed international nephrology society leaders, policy makers, and patient representatives to assess regional resources and ability to care for patients with kidney disease.
An 80-year-old man with stage 4 chronic kidney disease, 2 days of anuria, and an elevated serum κ to λ free light chain ratio had a bone marrow biopsy that stained positive for the plasma cell marker CD138. What would you do next?
This qualitative study analyzes the illness experience of undocumented immigrants with end-stage renal disease who lack access to scheduled hemodialysis.
This analysis of 3 community-based cohort studies determines absolute rates and risk differences of incident heart failure, coronary heart disease, and stroke in participants with vs without chronic kidney disease.
This cohort study uses data from the National Inpatient Sample database to examine rates of in-hospital reperfusion and outcomes among renal transplant recipients hospitalized with ST-segment elevation myocardial infarction.
This randomized clinical trial evaluates whether fish oil or aspirin vs placebo is effective in reducing arteriovenous fistula failure in patients requiring hemodialysis.
This report describes findings from 2 randomized trials comparing the effect of the intravenous calcimimetic etelcalcetide vs placebo on serum parathyroid hormone (PTH) levels in patients with secondary hyperparathyroidism receiving hemodialysis.
This randomized trial compares the effects of the intravenous calcimimetic etelcalcetide vs the oral calcimimetic cinacalcet for reducing parathyroid hormone concentrations in adult patients undergoing hemodialysis with moderate to severe secondary hyperparathyroidism.
This case-control study assesses the use of bone scintigraphy to diagnose calciphylaxis in cases with the disease and in controls with end-stage renal disease without calciphylaxis.
This case report describes treatment of advanced basal cell carcinoma with vismodegib in the context of renal insufficiency.